Medicare Advantage incurs a $5.7 billion underwriting loss in 2024 due to increased utilization, medical inflation, and regulatory changes, impacting insurer profitability and market dynamics.
Morgan Stanley downgrades Humana amid Medicare Advantage concerns highlighting risks to its profitability and financial forecast. Understand the implications for insurers.
CMS's 2027 Proposed Rule for Medicare Advantage revises Star Ratings by focusing on clinical quality and member experience, delaying equity-focused rewards, and enhancing integrated care for dual-eligible populations.
Explore the CMS CY 2027 Proposed Rule's impact on Medicare Advantage quality measures, Star Ratings, and integration of dual-eligible members with Medicaid. Key insights for health plans and state agencies.
CMS releases 2027 Medicare Advantage and Part D proposed rule focusing on Star Ratings adjustments, regulatory burden reduction, and program spending projections.
CMS released 2027 proposed Medicare Advantage rules focusing on simplifying Star Ratings, expanding risk adjustment data use, and streamlining reporting requirements.
Federal court upholds CMS's star rating methods after Humana challenges foreign language interpreter test policy, impacting Medicare Advantage market competition and insurer revenues.
Humana reports a significant drop in Medicare Advantage Star Ratings for 2025, impacting future revenues and leading to plan exits in several counties.
